Namsa宣布战略性收购徕博科早期开发医疗器械测试业务精选资产

美股速递
Jan 08

Namsa公司近日披露,已成功完成对徕博科(Labcorp Holdings Inc)旗下早期开发医疗器械测试业务部分精选资产的战略性收购。此次交易将强化Namsa在医疗器械测试领域的服务能力,拓展其早期开发阶段的业务布局。通过整合优质资源,Namsa旨在提升综合解决方案水平,为全球医疗器械客户提供更高效、专业的支持服务。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10